Renhe Pharmacy (000650.SZ) Earnings Analysis

Renhe Pharmacy (000650.SZ) has no confirmed upcoming earnings date. Trailing P/E 20.33.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 000650.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 000650.SZ. This page updates as the calendar is published.

000650.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-06-300.09011 CNYn/an/an/a
2025-04-250.04784 CNYn/an/an/a
2025-03-310.1174 CNYn/an/an/a
2024-10-280.0567 CNYn/an/an/a

000650.SZ valuation and analyst view

Trailing P/E20.33
Trailing EPS0.26385 CNY
Price / book1.16
Dividend yield2.83%
Market cap7.40B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Renhe Pharmacy (000650.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 000650.SZ. This page updates as the calendar is published.

Did 000650.SZ beat earnings last quarter?

Consensus estimate data was not available for 000650.SZ's 2025-06-30 report.

What is 000650.SZ's current P/E ratio and EPS?

000650.SZ trades at a trailing P/E of 20.33 on trailing EPS of 0.2638530560195482 CNY.

What do analysts rate 000650.SZ?

000650.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.